Oncology
Clinical research in non-small cell lung cancer, with a focus on adenocarcinoma of the lung that is locally advanced or metastatic and not suitable for curative surgery or radiotherapy. The studies examine targeted treatment options for advanced disease.
- Lazertinib
- Gefitinib
- Progression-free survival
The oncology portfolio is centered on treatment efficacy in advanced lung cancer settings.
Allergy and Immunology
Research in chronic spontaneous urticaria, addressing persistent symptoms and disease control in adults affected by recurrent hives and related skin manifestations.
- Lesigercept
- UAS7
- Placebo-controlled evaluation
This area reflects interest in symptom reduction and improvement in urticaria severity measures.
Targeted Therapeutics
The sponsor’s clinical activity includes development of precision oncology and biologic approaches aimed at disease-specific pathways in cancer and immune-mediated conditions.
- Targeted cancer therapy
- Biologic therapy
- Advanced disease management
These programs connect molecularly directed treatment strategies with unmet needs in oncology and inflammatory disease.
